Oridonin, a diterpenoid from Rabdosia rubescens, inhibits HK1, disrupts glycolysis, and reduces lactate production, which not only suppresses bladder cancer progression but also enhances CD8+ T cell cytotoxicity through PD-L1 downregulation147. Here, CD274 is linked to urinary bladder carcinoma.